본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

American journal of obstetrics and gynecology v.217 no.6, 2017년, pp.676.e1 - 676.e11   SCI SCIE
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Trends in contraceptive use according to HIV status among privately insured women in the United States

Haddad, Lisa B. (Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA ) ; Monsour, Michael (Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA ) ; Tepper, Naomi K. (Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA ) ; Whiteman, Maura K. (Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA ) ; Kourtis, Athena P. (Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA ) ; Jamieson, Denise J. (Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA ) ;
  • 초록  

    Background There is limited information on the patterns and trends of contraceptive use among women living with HIV, compared with noninfected women in the United States. Further, little is known about whether antiretroviral therapy correlates with contraceptive use. Such information is needed to help identify potential gaps in care and to enhance unintended pregnancy prevention efforts. Objective We sought to compare contraceptive method use among HIV-infected and noninfected privately insured women in the United States, and to evaluate the association between antiretroviral therapy use and contraceptive method use. Study Design We used a large US nationwide health care claims database to identify girls and women ages 15-44 years with prescription drug coverage. We used diagnosis, procedure, and National Drug Codes to assess female sterilization and reversible prescription contraception use in 2008 and 2014 among women continuously enrolled in the database during 2003 through 2008 or 2009 through 2014, respectively. Women with no codes were classified as using no method; these may have included women using nonprescription methods, such as condoms. We calculated prevalence of contraceptive use by HIV infection status, and by use of antiretroviral therapy among those with HIV. We used multivariable polytomous logistic regression to calculate unadjusted and adjusted odds ratios and 95% confidence intervals for female sterilization, long-acting reversible contraception, and short-acting hormonal contraception compared to no method. Results While contraceptive use increased among HIV-infected and noninfected women from 2008 through 2014, in both years, a lower proportion of HIV-infected women used prescription contraceptive methods (2008: 17.5%; 2014: 28.9%, compared with noninfected women (2008: 28.8%; 2014: 39.8%, P Conclusion Despite the safety of reversible contraceptives for women with HIV, use of prescription contraception continues to be lower among privately insured HIV-infected women compared to noninfected women, particularly among those receiving antiretroviral therapy.


  • 주제어

    antiretroviral therapy .   contraception .   HIV.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기